Cairncross JG - Search Results

1

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN. Cairncross JG, et al. J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9. doi: 10.1093/jnci/90.19.1473. J Natl Cancer Inst. 1998. PMID: 9776413

2

Imaging correlates of molecular signatures in oligodendrogliomas.

Megyesi JF, Kachur E, Lee DH, Zlatescu MC, Betensky RA, Forsyth PA, Okada Y, Sasaki H, Mizoguchi M, Louis DN, Cairncross JG. Megyesi JF, et al. Among authors: cairncross jg. Clin Cancer Res. 2004 Jul 1;10(13):4303-6. doi: 10.1158/1078-0432.CCR-04-0209. Clin Cancer Res. 2004. PMID: 15240515

3

Aggressive oligodendroglioma: a chemosensitive tumor.

Cairncross JG, Macdonald DR, Ramsay DA. Cairncross JG, et al. Neurosurgery. 1992 Jul;31(1):78-82. doi: 10.1227/00006123-199207000-00011. Neurosurgery. 1992. PMID: 1641113 Review.

4

p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression.

van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG. van Meyel DJ, et al. Among authors: cairncross jg. J Natl Cancer Inst. 1994 Jul 6;86(13):1011-7. doi: 10.1093/jnci/86.13.1011. J Natl Cancer Inst. 1994. PMID: 8007011

5

Current treatment of oligodendrogliomas.

Perry JR, Louis DN, Cairncross JG. Perry JR, et al. Among authors: cairncross jg. Arch Neurol. 1999 Apr;56(4):434-6. doi: 10.1001/archneur.56.4.434. Arch Neurol. 1999. PMID: 10199331 Review. No abstract available.

6

Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.

Bauman GS, Ino Y, Ueki K, Zlatescu MC, Fisher BJ, Macdonald DR, Stitt L, Louis DN, Cairncross JG. Bauman GS, et al. Among authors: cairncross jg. Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):825-30. doi: 10.1016/s0360-3016(00)00703-3. Int J Radiat Oncol Biol Phys. 2000. PMID: 11020580

7

Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.

Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN. Ino Y, et al. Among authors: cairncross jg. Clin Cancer Res. 2001 Apr;7(4):839-45. Clin Cancer Res. 2001. PMID: 11309331

8

PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.

Sasaki H, Zlatescu MC, Betensky RA, Ino Y, Cairncross JG, Louis DN. Sasaki H, et al. Among authors: cairncross jg. Am J Pathol. 2001 Jul;159(1):359-67. doi: 10.1016/S0002-9440(10)61702-6. Am J Pathol. 2001. PMID: 11438483 Free PMC article.

9

Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms.

Zlatescu MC, TehraniYazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN, Cairncross JG. Zlatescu MC, et al. Among authors: cairncross jg. Cancer Res. 2001 Sep 15;61(18):6713-5. Cancer Res. 2001. PMID: 11559541

10

Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1.

Cahill DP, Louis DN, Cairncross JG. Cahill DP, et al. Among authors: cairncross jg. CNS Oncol. 2015;4(5):287-94. doi: 10.2217/cns.15.32. Epub 2015 Nov 6. CNS Oncol. 2015. PMID: 26545048 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters